Öberg, D., Yanover, E., Adam, V., Sweeney, K., Costas, C., Lemoine, N. R., & Halldén, G. (2010). Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant (AdΔΔ) in prostate and pancreatic cancers.
Citação norma ChicagoÖberg, Daniel, Eva Yanover, Virginie Adam, Katrina Sweeney, Celina Costas, Nick R. Lemoine, and Gunnel Halldén. Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant (AdΔΔ) in Prostate and Pancreatic Cancers. 2010.
MLA citiranjeÖberg, Daniel, et al. Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant (AdΔΔ) in Prostate and Pancreatic Cancers. 2010.
Opozorilo: Ti citati niso vedno 100% točni.